Asian Surveying & Mapping
Breaking News
Drones to undertake India’s ‘biggest’ land survey exercise
Maharashtra State will use drones to undertake the “biggest”...
Uzbekistan may work on common space project with Central Asian countries
Kazakhstan presented the space project to the heads of...
EU unveils Earth observation program
The European Union’s (EU) Earth observation program, which can...
European Union brings Copernicus Programme to Philippines
THE European Union Delegation to the Philippines last March...
Drones retain their buzz at Japanese trade show, with industrial uses expected to bolster growth
CHIBA - With the market for business-use unmanned aircraft...
China GEO supports Brazil dam collapse disaster response
Following the devastating January 2019 Brazilian dam collapse, Chinese...
ISRO’s big achievement: South American countries look towards India for low cost satellite launches
Experts have indicated to Financial Express Online that in...
Malaysian Space Agency created to maximize efficiency and impact
WHILE speculation was hot in the early stages of...
Isro, French agency to launch sat network to monitor Indian
NEW DELHI: The Indian Space Research Organisation (Isro) and...
Vice President M Venkaiah Naidu’s Paraguay visit: India offers its space expertise to the South American nation
India offers its expertise and experience in using space...
  • Jan 10, 2019
  • Comments Off on Leica Biosystems Receives US Patent for RTF Extreme Speed Scanning Technology
  • Corporate, News
  • 129 Views

January 10th, 2019
Leica Biosystems Receives US Patent for RTF Extreme Speed Scanning Technology

VISTA, Calif.– Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has granted it a patent for RTF, its breakthrough “Real-Time Focusing” technology (US patent 9,841,590). This will enable high volume, extremely fast line scanning of anatomic pathology slides.

“RTF technology dramatically improves slides scanning speed while delivering excellent optical focus. Extremely short scan times can now be achieved at 40x magnification,” said Jerome Clavel, General Manager of Leica Biosystems Pathology Imaging. “We have been working internally with RTF technology for quite some time. We will be integrating and commercializing RTF into our next-generation digital pathology platform shortly.”

Leica Biosystems has been testing RTF with UCLA (University of California, Los Angeles), and other leading institutions worldwide to fine-tune its application in a high-volume laboratory setting.

“We are excited about the potential of RTF to significantly scale up digital pathology operations by moving high volume and high throughput scanning into the histology lab,” said Dr. W. Dean Wallace, Professor, Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA. “By implementing RTF technology into our workflow, we will soon be able to take the next crucial step in the development of digital pathology.”

Leica Biosystems has a large global R&D footprint with 12 development centers. Its dedicated teams of engineers develop innovative technologies with the goal of enabling pathologists to efficiently make highly confident same-day diagnoses. Aperio Technologies, now part of Leica Biosystems, introduced high-speed line scanning into Digital Pathology years ago, and holds a comprehensive patent portfolio for this technology in key geographies.

The statements in this press release are forward looking and any references to projected timelines, anticipated functionality or potential claims are only speculative at this state.

Aperio digital pathology products using RTF have not been cleared for clinical diagnostic use in the U.S.A.

About Leica Biosystems
Leica Biosystems (LeicaBiosystems.com) is a cancer diagnostics company and a global leader in workflow solutions, offering the most comprehensive portfolio from biopsy to diagnosis. With unique expertise, we are dedicated to driving innovations that connect people across radiology, pathology, surgery and oncology. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture.  Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is headquartered in Germany and operates in over 100 countries.